Brown Miller Wealth Management LLC reduced its holdings in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 9.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,109 shares of the company’s stock after selling 1,658 shares during the quarter. Brown Miller Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $529,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Operose Advisors LLC acquired a new position in ARK Genomic Revolution ETF during the third quarter worth approximately $25,000. Stephens Consulting LLC acquired a new stake in ARK Genomic Revolution ETF during the third quarter worth about $28,000. Allworth Financial LP raised its holdings in shares of ARK Genomic Revolution ETF by 65.3% in the 3rd quarter. Allworth Financial LP now owns 1,425 shares of the company’s stock worth $40,000 after purchasing an additional 563 shares during the period. High Net Worth Advisory Group LLC lifted its stake in shares of ARK Genomic Revolution ETF by 80.9% in the 1st quarter. High Net Worth Advisory Group LLC now owns 1,118 shares of the company’s stock valued at $51,000 after purchasing an additional 500 shares in the last quarter. Finally, BKM Wealth Management LLC acquired a new stake in ARK Genomic Revolution ETF during the 4th quarter worth approximately $78,000.
ARK Genomic Revolution ETF Price Performance
Shares of ARKG traded up $0.19 during midday trading on Thursday, reaching $28.74. 2,296,036 shares of the company were exchanged. The company’s fifty day moving average is $29.85 and its 200-day moving average is $28.76.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Want to Profit on the Downtrend? Downtrends, Explained.
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What are earnings reports?
- Disney Stock Catches 3 Upgrades In a Single Week
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
